Published in TB and Outbreaks Week, November 15th, 1999
The studies were presented at the First International Congress on Cytokines/Chemokines in Infectious Diseases, held September 8-10, 1999, in Bethesda, Maryland.
Bacillus Calmette-Guerin (BCG) vaccine has provided different levels of protection against tuberculosis ranging from 0-80 percent.
"The search for better vaccines has continued," C. Jagannath and colleagues from the University of Texas Health Science Center wrote in a poster presented at the conference.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.